Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.
Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits
Pfizer dropped development of lotiglipron, its investigational GLP-1 receptor agonist for obesity, due to elevated liver enzymes; could other agents in the drug class carry